A phase Ia/Ib study of an anti-TIM-3 antibody (LY3321367) monotherapy or in combination with an anti-PD-L1 antibody (LY3300054): Interim safety, efficacy, and pharmacokinetic findings in advanced cancers Meeting Abstract
| Authors: | Harding, J. J.; Patnaik, A.; Moreno, V.; Stein, M.; Jankowska, A. M.; de Mendizabal, N. V.; Liu, Z. T.; Koneru, M.; Calvo, E. |
| Abstract Title: | A phase Ia/Ib study of an anti-TIM-3 antibody (LY3321367) monotherapy or in combination with an anti-PD-L1 antibody (LY3300054): Interim safety, efficacy, and pharmacokinetic findings in advanced cancers |
| Meeting Title: | 2019 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 8 Suppl. |
| Meeting Dates: | 2019 Feb 28-Mar 2 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-03-10 |
| Language: | English |
| ACCESSION: | WOS:000489109600028 |
| DOI: | 10.1200/JCO.2019.37.8_suppl.12 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 12 -- Source: Wos |
